Glycine — Research Profile

Glycine improves sleep through two mechanisms: (1) it activates NMDA receptors in the suprachiasmatic nucleus, promoting core body temperature reduction — a key trigger for sleep onset ^[1]; (2) it acts as an inhibitory neurotransmitter, calming neural activity. Unlike sedative sleep aids, glycine does not cause grogginess or dependence.

Possibly. Meléndez-Hevia et al. calculated that the body needs about 15 g of glycine daily for optimal collagen and metabolic functions, but typical diets provide only 3-5 g. The body can synthesize some glycine, but not enough for optimal collagen production. Supplementing 3-5 g/day may fill this gap.

Yes, this is a popular and evidence-supported combination. Glycine (3 g) and magnesium glycinate (200-400 mg elemental magnesium) work through complementary mechanisms. Magnesium glycinate actually provides some glycine as the chelating amino acid. Together they are one of the best natural sleep support stacks.

Trials have used plain oral glycine -- powder dissolved in water or capsules -- and the sleep studies specifically used 3 g of glycine powder about 30 minutes before bed. There is no head-to-head evidence that magnesium glycinate, buffered, or other 'enhanced' forms outperform ordinary glycine for the outcomes actually studied. Glycine tastes mildly sweet, so many people take the powder dissolved in liquid.

The most consistent human finding is improved subjective sleep quality: 3 g before bed shortened latency to sleep onset and to slow-wave sleep and reduced daytime fatigue in poor sleepers. As a glutathione precursor, glycine combined with N-acetylcysteine restored red-cell glutathione and lowered oxidative-stress markers in older adults. Other proposed uses (metabolic and psychiatric) rest on small trials with high risk of bias, so that evidence remains preliminary.

For sleep, trials used 3 g taken about 30 minutes before bedtime. The glutathione-restoration research used roughly 100 mg/kg/day (about 7 g for a 70 kg adult) alongside N-acetylcysteine. Much higher amounts (0.2-0.8 g/kg/day) appear only in supervised psychiatric trials and are not a general recommendation; there is no single established daily dose that applies across all uses.

For sleep the timing is specific: the trials that showed a benefit gave 3 g about 30 minutes before bedtime. For its glutathione-precursor role, time of day was not a studied variable -- the older-adult study simply dosed daily for two weeks. So take it pre-bed if the goal is sleep; for other uses, time of day has not been shown to matter.

Reported side effects are few: the 3 g sleep studies did not document meaningful adverse effects. However, the systematic review covering higher-dose and clinical studies noted that adverse-effect reporting was generally sparse and study quality low, so the side-effect profile at large or long-term doses is not well characterized. Very high amino-acid doses can plausibly cause gastrointestinal discomfort, but this was not systematically measured in the trials.

The clearest interaction is with clozapine: in a 12-week trial, adding 30 g/day of glycine to clozapine produced no benefit while the clozapine-only group improved, leading the authors to conclude that glycine 'may interfere with the antipsychotic efficacy' of clozapine. People taking clozapine should therefore avoid supplemental glycine. Because glycine acts at the NMDA-receptor glycine site, caution is reasonable with other drugs targeting that system; broader interaction data for typical low-dose use are limited.

The people most likely to benefit are those with poor subjective sleep, where 3 g before bed improved sleep quality and daytime alertness. Older adults with depleted glutathione and elevated oxidative stress are a second evidence-based group, though the supporting study paired glycine with N-acetylcysteine. It is not established as useful for healthy people without a sleep complaint, and anyone taking clozapine should avoid it.

Sleep effects appear quickly: in trials giving 3 g about 30 minutes before bed, poor sleepers reported better subjective sleep quality and less daytime fatigue within the first nights, with polysomnography showing shorter latency to sleep onset. Other goals take longer -- schizophrenia trials ran 6-12 weeks, and the study that restored glutathione needed 2 weeks of daily dosing. Onset therefore depends entirely on what you are taking it for.

Human trials have been relatively short: a systematic review found healthy-adult studies lasted from a single dose up to 14 days, and studies in clinical populations up to about 4 months, so safety beyond a few months is not well characterized. Within those windows glycine was tolerated at doses from 3 g/day for sleep up to much higher amounts in supervised trials. No year-scale supplementation data exist to confirm long-term safety.

No tolerable upper intake level has been established for supplemental glycine. Medically supervised schizophrenia trials used 0.2-0.8 g/kg body weight per day (up to roughly 60 g/day) for 6-12 weeks without reported serious toxicity, but the systematic review cataloguing those studies noted that adverse-effect reporting was sparse, so a true ceiling is undefined. Everyday sleep or wellness use sits far lower, around 3 g.

The best-studied pairing is glycine with N-acetylcysteine (a cysteine source): together at about 100 mg/kg/day each for 2 weeks they restored red-blood-cell glutathione and lowered oxidative-stress markers in older adults, because both are glutathione precursors. For sleep, glycine has been used on its own at 3 g before bed. No harmful combinations are documented, but pairing is only evidence-based where the second compound shares a biochemical pathway with glycine.

Glycine is a single defined amino acid, so look for a product that is simply pharmaceutical- or USP-grade glycine with no proprietary blends that hide the actual amount. Because the sleep evidence rests on a specific 3 g dose taken before bed, choose a powder or capsule format that lets you measure that amount accurately. There is no marker compound to standardize to, so third-party purity testing is the main quality differentiator.